Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219085 · ClinicalTrials.gov registry record · NA
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT04219085 is a NA study that has completed, run by Yale University. The registered enrollment target is 65 participants.
The verdict
NCT04219085, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
This study will utilize continuous glucose monitoring in women with A2 gestational diabetes. Women will be randomized to continuous glucose monitoring or routine care with fingersticks to check their blood glucose four times daily. It is hypothesized that women in the continuous glucose monitoring arm will have a lower incidence of the composite primary outcome, which includes the following variables: perinatal death, shoulder dystocia, birth weight greater than 4,000 grams, NICU admission for treatment of hypoglycemia (blood glucose level \<40mg/dL) and birth trauma, including fracture or nerve palsy.
Interventions
- DEVICE Continuous Glucose Monitor
- OTHER Routine Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04219085
The ClinicalTrials.gov registry entry for NCT04219085 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor is the first listed.
NCT04219085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04219085 about?
NCT04219085 is a clinical study titled "CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes". This study will utilize continuous glucose monitoring in women with A2 gestational diabetes. Women will be randomized to continuous glucose monitoring or routine care with fingersticks to check their blood glucose four times daily. It is hypothesized that women in the continuous glucose monitoring a...
What is the current status of trial NCT04219085?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2020-09-01. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT04219085?
The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Routine Care (OTHER).
Who is sponsoring clinical trial NCT04219085?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.